Search Results - "pharmacokinetics"

Pharmacokinetic study of a novel oral formulation of S-adenosylmethionine (MSI-195) in healthy subjects: dose escalation, food effect and comparison to a commercial nutritional supplement product by Beth R. Cameron, Ludvina Ferreira, I. David MacDonald

Connect to this object online.

Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects by Ryu H, Kim HC, Jeon I, Jang IJ, Cho JY, Kim KT, Oh J

Connect to this object online.

Determination of (-)-epigallocatechin-3-gallate octaacetate and its metabolites in plasma of rats for pharmacokinetic study by ultra-performance-liquid-chromatography coupled to quadrupole-time-of-flight-mass-spectrometry by Kai On Chu, Kai On Chu, Gene Chi Wai Man, Sze Wan Hung, Tak Hang Chan, Tak Hang Chan, Wai Yip Thomas Lee, Kwok Ping Chan, Chi Pui Pang, Chi Pui Pang, Chi Chiu Wang, Chi Chiu Wang

Connect to this object online.

Can semipermeable membranes coating materials influence in vivo performance for paliperidone tri-layer ascending release osmotic pump tablet: In vitro evaluation and in vivo pharmacokinetics study by Guangjing Li, Yongjun Wang, Hongming Chen, Donglei Leng, Panqin Ma, Yanjie Dong, Lifang Gao, Zhonggui He

Connect to this object online.

Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review by Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, Qureshi AI

Connect to this object online.

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19 by Binbin Xia, Li Zheng, Yali Li, Wenfang Sun, Yang Liu, Liushui Li, Jingyao Pang, Jing Chen, Jiaxin Li, Hua Cheng

Connect to this object online.

Formulation and Development of Oral Fast-Dissolving Films Loaded with Nanosuspension to Augment Paroxetine Bioavailability: In Vitro Characterization, Ex Vivo Permeation, and Pharmacokinetic Evaluation in Healthy Human Volunteers by Ahmed Hassen Elshafeey, Rania Moataz El-Dahmy

Connect to this object online.

Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients by Jaydeep K. Srimani, Paul M. Diderichsen, Michael J. Hanley, Karthik Venkatakrishnan, Richard Labotka, Neeraj Gupta

Connect to this object online.

Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects by Rhee SJ, Lee S, Yoon SH, Cho JY, Jang IJ, Yu KS

Connect to this object online.

An overview of learning methodology for clinical pharmacokinetics course during the COVID-19 pandemic / Hannani Mawarddah Muhammad Abdul Hafidz, Nur Wahida Zulkifli and Farhana Fakhira Ismail by Muhammad Abdul Hafidz, Hannani Mawarddah, Zulkifli, Nur Wahida, Ismail, Farhana Fakhira

Link Metadata

Molecular Science for Drug Development and Biomedicine

Subjects: “…pharmacokinetics/pharmacodynamics…”
DOAB: download the publication
DOAB: description of the publication

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? by Kim CO, Oh ES, Kim H, Park MS

Connect to this object online.

SLCO1B1 and CYP3A4 allelic variants associated with pharmacokinetic interactions and adverse reactions induced by simvastatin and atorvastatin used in Peru: Clinical implications by Angel T. Alvarado, Ana María Muñoz, Roberto O. Ybañez-Julca, Mario Pineda-Pérez, Nesquen Tasayco-Yataco, María R. Bendezú, Jorge A. García, Felipe Surco-Laos, Haydee Chávez, Doris Laos-Anchante, Aura Molina-Cabrera, Carmela Ferreyra-Paredes, Nelly Vega-Ramos, Patricia Castillo-Romero, Javier Chávez-Espinoza, Juan Panay-Centeno, Eliades Yarasca-Carlos

Connect to this object online.

A picogram BA-ELISA quantification assay for rLj-RGD3, a platelet fibrinogen receptor antagonist, in the rat plasma and its application to a pharmacokinetic study. by Yuping Wang, Zhien Liu, Guozhu Han, Ping Yu, Xiaobo Yang, Jihong Wang, Li Lv

Connect to this object online.

Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P‐glycoprotein-cytochrome P450 3A4 dual substrates by Xian Pan, Shinji Yamazaki, Sibylle Neuhoff, Mian Zhang, Venkatesh Pilla Reddy

Connect to this object online.

Investigating Changes in Pharmacokinetics of Steroidal Alkaloids from a Hydroethanolic <i>Fritillariae thunbergii</i> Bulbus Extract in 2,4-Dinitrobenzene Sulfonic Acid-Induced Colitis Rats by Ji-Soo Jeong, Jeong-Won Kim, Jin-Hwa Kim, Eun-Hye Chung, Je-Won Ko, Youn-Hwan Hwang, Tae-Won Kim

Connect to this object online.

Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer biphasic IR/ER combination formulation, under fed and fasted conditions by Devarakonda K, Morton T, Margulis R, Giuliani M, Barrett T

Connect to this object online.

Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation by Wenqian Yang, Zimeng Yang, Jieru Liu, Dan Liu, Yongjun Wang

Connect to this object online.

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against <i>Pseudomonas aeruginosa</i> for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model by Jessica R. Tait, Hajira Bilal, Kate E. Rogers, Yinzhi Lang, Tae-Hwan Kim, Jieqiang Zhou, Steven C. Wallis, Jürgen B. Bulitta, Carl M. J. Kirkpatrick, David L. Paterson, Jeffrey Lipman, Phillip J. Bergen, Jason A. Roberts, Roger L. Nation, Cornelia B. Landersdorfer

Connect to this object online.

The pharmacokinetics of oral trazpiroben (TAK‐906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study by Jatinder K. Mukker, George Dukes, Max Tolkoff, Lisi Wang, Cristina Almansa, Susanna Y. Huh, Mitsuhiro Nishihara, Diane Ramsden, Chunlin Chen

Connect to this object online.